Company / Inventory
Haemonetics Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$365.1M
FY2025
5-year range
$259.4M / $365.1M
FY2021-FY2025
Trend
+15.1%
vs FY2024
Sector context
#53 of 118
Health Care
What the data says
At $365M, Haemonetics's inventory ranks #53 of 118 in the Health Care sector. Inventory has fluctuated over the past 10 years, ranging from $161M in FY2018 to $365M in FY2025.
Based on SEC 10-K filings.
$365M in FY2025 with a 5-year CAGR of +6.2%.
Improved from $259M to $365M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
#53 of 118 in Health CareTop 45% of 118This company $365.1M Sector average $1.4B
▼
-74.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, inventory increased 15.1% year-over-year.
- Ranks #53 out of 118 companies in the Health Care sector.
- Lowest inventory in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $365.1M | +15.1% |
| FY2024 | $317.2M | +22.3% |
| FY2023 | $259.4M | -11.5% |
| FY2022 | $293.0M | -9.2% |
| FY2021 | $322.6M | +19.4% |
| FY2020 | $270.3M | +39.1% |
| FY2019 | $194.3M | +20.9% |
| FY2018 | $160.8M | -9.1% |
| FY2017 | $176.9M | -5.4% |
| FY2016 | $187.0M | -11.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026